只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-08 2026-07-10 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 20,000 | US$133.63 | US$267.26万 | 995,987 | SEC |
| 2026-07-01 2026-07-02 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl Officer · Chief Medical Officer | 卖出（S） | 5,500 | US$132.74 | US$730,070.00 | 177,873 | SEC |
| 2026-06-22 2026-06-24 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 80,000 | US$132.54 | US$1060.32万 | 1,015,987 | SEC |
| 2026-06-22 2026-06-24 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl Officer · Chief Medical Officer | 卖出（S） | 26,400 | US$132.60 | US$350.06万 | 179,248 | SEC |
| 2026-06-10 2026-06-12 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 7,654 | US$82.78 | US$633,598.12 | 1,101,563 | SEC |
| 2026-06-10 2026-06-12 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 1,080 | US$84.18 | US$90,914.40 | 1,100,483 | SEC |
| 2026-06-10 2026-06-12 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 6,770 | US$82.21 | US$556,561.70 | 1,109,217 | SEC |
| 2026-06-10 2026-06-12 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 1,577 | US$85.19 | US$134,344.63 | 1,098,906 | SEC |
| 2026-06-10 2026-06-12 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 2,305 | US$86.27 | US$198,852.35 | 1,096,601 | SEC |
| 2026-06-10 2026-06-12 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 614 | US$86.89 | US$53,350.46 | 1,095,987 | SEC |
| 2026-06-03 2026-06-05 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl Officer · Chief Medical Officer | 卖出（S） | 5,500 | US$78.71 | US$432,905.00 | 205,648 | SEC |
| 2026-05-13 2026-05-15 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 18,659 | US$82.05 | US$153.1万 | 1,117,328 | SEC |
| 2026-05-13 2026-05-15 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 1,341 | US$82.58 | US$110,739.78 | 1,115,987 | SEC |
| 2026-05-06 2026-05-08 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl Officer · Chief Medical Officer | 卖出（S） | 1,800 | US$84.60 | US$152,280.00 | 207,023 | SEC |
| 2026-05-06 2026-05-08 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl Officer · Chief Medical Officer | 卖出（S） | 3,700 | US$83.92 | US$310,504.00 | 208,823 | SEC |
| 2026-05-01 2026-05-04 | APGE Apogee Therapeutics, Inc. | Henderson Jane Officer · Chief Financial Officer | 卖出（S） | 289 | US$83.16 | US$24,033.24 | 173,371 | SEC |
| 2026-05-01 2026-05-04 | APGE Apogee Therapeutics, Inc. | Henderson Jane Officer · Chief Financial Officer | 卖出（S） | 811 | US$81.02 | US$65,707.22 | 174,560 | SEC |
| 2026-05-01 2026-05-04 | APGE Apogee Therapeutics, Inc. | Henderson Jane Officer · Chief Financial Officer | 卖出（S） | 900 | US$82.60 | US$74,340.00 | 173,660 | SEC |
| 2026-04-16 2026-04-17 | APGE Apogee Therapeutics, Inc. | Henderson Jane Officer · Chief Financial Officer | 卖出（S） | 2,000 | US$90.00 | US$180,000.00 | 175,371 | SEC |
| 2026-04-08 2026-04-10 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 2,000 | US$83.26 | US$166,520.00 | 1,133,187 | SEC |
| 2026-04-08 2026-04-10 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 200 | US$85.00 | US$17,000.00 | 1,132,987 | SEC |
| 2026-04-08 2026-04-10 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director,Officer · Chief Executive Officer | 卖出（S） | 17,800 | US$82.48 | US$146.81万 | 1,135,187 | SEC |
| 2026-04-08 2026-04-10 | AACPU Apogee Acquisition Corp | Smith Jeffrey Andrew Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 470,000 | US$0.00 | US$0.00 | 470,000 | SEC |
| 2026-04-08 2026-04-10 | AACPU Apogee Acquisition Corp | APOGEE ACQUISITION SPONSOR LLC TenPercentOwner | 买入（P） | 470,000 | US$0.00 | US$0.00 | 470,000 | SEC |
| 2026-04-01 2026-04-03 | APGE Apogee Therapeutics, Inc. | Henderson Jane Officer · Chief Financial Officer | 卖出（S） | 900 | US$84.46 | US$76,014.00 | 178,471 | SEC |
| 2026-04-01 2026-04-03 | APGE Apogee Therapeutics, Inc. | Henderson Jane Officer · Chief Financial Officer | 卖出（S） | 1,100 | US$85.46 | US$94,006.00 | 177,371 | SEC |
| 2026-04-01 2026-04-03 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl Officer · Chief Medical Officer | 卖出（S） | 2,698 | US$84.31 | US$227,468.38 | 211,200 | SEC |
| 2026-04-01 2026-04-03 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl Officer · Chief Medical Officer | 卖出（S） | 2,702 | US$85.33 | US$230,561.66 | 208,498 | SEC |
| 2026-04-01 2026-04-03 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl Officer · Chief Medical Officer | 卖出（S） | 100 | US$85.89 | US$8,589.00 | 208,398 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| APOG | 30,529.0762 | 0 | 44,994.089 | 67.85% | B, Q, N |